Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives - Normandie Université Access content directly
Journal Articles Cancer Gene Therapy Year : 2001

Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives

Abstract

Polyethylenimine (PEI) derivatives are potent polycationic nonviral vectors for gene transfer. The gene transfer efficiency of glucosylated and galactosylated PEI derivatives was optimized using green fluorescent protein gene as reporter gene in FaDu and PANC3 human carcinoma cell lines. Glucosylated or galactosylated PEI derivatives were found to be slightly less cytotoxic than unsubstituted PEI. Gene transfer efficiency was found to be related to DNA/cell number ratio and optimal gene transfer efficiency was achieved at 4 microg DNA/10(5) cells. PEI-DNA complexes were found to enter cells rapidly and were detected into cytoplasmic vesicles 2 hours post-transfection. Green fluorescent protein gene expression was detected 4-6 hours after transfection and reached maximal value 24 hours post-transfection. The results achieved demonstrated that glucosylated PEI yield higher and longer gene transfer efficiency than unsubstituted PEI. Using glucosylated PEI allowed to achieve significant gene transfer in more than 10% of the total cell population for more than 4 days. These data were then applied to p53 gene transfer in PANC3 cells bearing p53 gene deletion and consequently unable to initiate apoptosis. Using glucosylated PEI, p53 gene transfer was successfully achieved with subsequent recovery of p53 mRNA expression and transient P53 protein expression. P53 protein functionality was further demonstrated because transfected cells underwent apoptosis.

Domains

Cancer

Dates and versions

hal-02179730 , version 1 (11-07-2019)

Identifiers

Cite

Jean-Louis Merlin, Gilles Dolivet, Christophe Dubessy, Estelle Festor, Robert-Michel Parache, et al.. Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives. Cancer Gene Therapy, 2001, 8 (3), pp.203-210. ⟨10.1038/sj.cgt.7700289⟩. ⟨hal-02179730⟩
66 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More